Design Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DSGN)

CUSIP: 25056L103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
61,756,000
Total 13F shares
38,119,020
Share change
+3,292,284
Total reported value
$357,552,417
Put/Call ratio
2.2%
Price per share
$9.38
Number of holders
116
Value change
+$35,421,791
Number of buys
65
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 25056L103?
CUSIP 25056L103 identifies DSGN - Design Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Design Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DSGN) as of Q4 2025

As of 31 Dec 2025, Design Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DSGN) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,119,020 shares. The largest 10 holders included SR One Capital Management, LP, Point72 Asset Management, L.P., Logos Global Management LP, BAKER BROS. ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, Vivo Capital, LLC, Almitas Capital LLC, RA CAPITAL MANAGEMENT, L.P., and Driehaus Capital Management LLC. This page lists 116 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.